[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100482726":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":30,"centralContacts":30,"locations":39,"responsibleParty":63,"collaborators":30,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":67,"sex":73,"minAge":74,"maxAge":30,"enrollmentInfo":75,"targetDuration":30,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":42,"whyStopped":30,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Hospital Universitari Vall d'Hebron Research Institute","OTHER",[8,15,20],{"label":9,"type":10,"description":11,"interventionNames":12},"ECG Smartwatch for up to 1 year","ACTIVE_COMPARATOR","Cardiac monitoring with a smartwatch that support the recording of a single-lead electrocardiogram (ECG) over 1 year after the acute phase of cryptogenic stroke. Simultaneously, a continuous cardiac monitoring will be performed using an Insertable Cardiac Monitor (ICM)",[13,14],"Device: ECG smartwatch","Device: Insertable Cardiac Monitor (ICM)",{"label":16,"type":10,"description":17,"interventionNames":18},"Holter monitoring for up to 1 year","Cardiac monitoring with an external holter device for 30 days after the acute phase of cryptogenic stroke and 15 additional days of extended use every 3 months up to 1 year",[19],"Device: External ECG Monitoring",{"label":21,"type":6,"description":22,"interventionNames":23},"Control group","Regular cardiac monitoring with an external holter device for 30 days after the acute phase of cryptogenic stroke",[19],[25,31,35],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DEVICE","ECG smartwatch","Testing ECG smartwatch to detect AF or potential signs of AF",[9],null,{"type":26,"name":32,"description":33,"armGroupLabels":34,"otherNames":30},"Insertable Cardiac Monitor (ICM)","Gold-standard cardiac monitor for comparison of testing device (ECG smartwatch)",[9],{"type":26,"name":36,"description":37,"armGroupLabels":38,"otherNames":30},"External ECG Monitoring","Regular cardiac monitor for diagnosis of AF",[21,16],[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Hospital Universitari Vall d'Hebron","RECRUITING","Barcelona","Catalonia","08035","Spain","ES",{"type":49,"coordinates":50},"Point",[51,52],2.15899,41.38879,{"lat":52,"lon":51},[55,61],{"name":56,"role":57,"phone":58,"phoneExt":59,"email":60},"Jorge Pagola, Neurologist","CONTACT","932746000","6364","jpagola@vhebron.net",{"name":56,"role":62,"phone":30,"phoneExt":30,"email":30},"PRINCIPAL_INVESTIGATOR",{"type":64,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100482726","smartwatch-and-external-holter-monitoring-to-detect-atrial-fibrillation-in-patients-with-cryptogenic-stroke-100482726",false,"NCT05565781","Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke","Impact of Non-invasive Remote Monitoring Via Wearable Technologies for Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke","SMARTTHUNDER","Inclusion Criteria:\n\n* Age greater to or equal to 55 years\n* Patients with diagnosis of cryptogenic stroke after a basic study that included neuroimaging, extra\u002Fintracranial vascular evaluation, 24-hour monitoring, and echocardiogram\n* Patients with acute cortical infarction with the presence of intracranial occlusion (preferably)\n* Modified Rankin Scale (mRS) lower to 4\n\nExclusion Criteria:\n\n* Diagnosis of lacunar infarction or transient ischemic attack (TIA)\n* Diagnosis of stroke of known source: atherothrombotic due to moderate or severe symptomatic extra\u002Fintracranial stenosis, major cardioembolic cause (atrial fibrillation, anterior or apical ventricular akinesis, causal PFO, post-AMI, flutter or mitral stenosis), unusual cause (thrombophilia, arterial dissection symptomatic, toxic)\n* Use of pacemakers\n* Circumstances that may preclude the clinical follow-up or reduce the possibilities of obtaining data to achieve the objectives of the study and\u002For limit contact with the investigator (for example, transfer to a social health center)\n* Unwillingness to the use of cardiac monitoring wearable devices\n* Not understanding study procedures","ALL","55 Years",{"count":76,"type":77},100,"ESTIMATED","INTERVENTIONAL",[80],"NA","Stroke recurrence largely depends on the detection of the cause and the control of vascular risk factors, with occult atrial fibrillation (AF) being one of the most important. Prolonged ambulatory cardiac monitoring is recommended for detecting occult AF. Currently, there are non-invasive monitoring devices such as the textile Holter that have proven to be useful for monitoring for up to 30 days but not longer. Another alternative is smartwatches, although they must be validated for use in the elderly population who have had a stroke.",[83,84],"Paroxysmal Atrial Fibrillation","Cryptogenic Stroke",[86],"Wearable Electronic Devices","2025-04-02",{"date":89,"type":90},"2025-04-04","ACTUAL",{"date":92,"type":90},"2022-03-28",{"date":94,"type":77},"2026-09-01",{"name":5,"class":6},1]